Olaf Ansorage

Menopause and Alzheimer’s disease: can hormone replacement therapy modify the risk? A narrative review

Alzheimer’s Disease (AD) prevalence and lifetime risk are higher in women than men. This led to the hypothesis that menopause, with its associated changes in female hormone homoeostasis, may be an AD risk factor modifiable by hormone replacement therapy (HRT). However, HRT is not...